2018 Announcements
Chair Letter to Shareholders
05 October 2018
This is a thank you to shareholders, investors, patients, clinicians, and all those who have continued to support CLINUVEL together with new shareholders who have recently gained confidence to join the CLINUVEL register. The Company’s performance of the past years, the first ever dividend declared, and progress towards US market entry are some of the main motivations to support the Company’s course at this point in time.